NANT immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NANT immunotherapy, covering 2025-02-21 to 2025-02-21. Get the full timeline:
Most recent: Clinical Trial Update: QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer [Phase 2]